ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
55 announcements with these filters
Religare Enterprises allotted 83,43,263 equity shares following warrant conversions, totaling ₹196.07 Crore. The allotment increases paid-up capital and concludes the 18-month warrant exercise period.
Religare Enterprises clarified an inadvertent 'audited' selection in its Q4FY26 XBRL financial results filing. The company is taking steps to submit corrected forms to the exchange.
Religare Enterprises reported FY26 consolidated total income of ₹8,493cr and PAT of ₹73.16cr. Management is restructuring via demerger into two listed entities: Health Insurance and Financial Services.
Religare Enterprises designated Group General Counsel Babu Rao Priya as Key Managerial Personnel. The move strengthens corporate governance and formalizes senior leadership responsibilities.
Religare Enterprises Limited filed its monitoring report for the ₹1,500.00 Crore warrant issue proceeds. The agency confirmed utilization aligns with specified objects without deviations.
Religare Enterprises Ltd reported revenue from operations of ₹2,467 Cr (+20.8% YoY) and net profit of ₹95.7 Cr (-36.5% YoY) for Q4 FY26.
Religare Enterprises reported FY26 consolidated revenue of ₹8,493.84 Crore, driven by 24% growth in health insurance. Strategic leadership appointments and a ₹1,500 Crore capital raise support growth.
Religare Enterprises approved closing its subsidiary, MIC Insurance Web Aggregator, by surrendering its license. The shutdown has no material impact on the company's consolidated financials.
Religare Enterprises updated its Key Managerial Personnel contact details for determining disclosure materiality. This administrative filing ensures regulatory compliance under SEBI LODR Regulations.
Religare Enterprises designated Mr. Babu Rao Priya as Key Managerial Personnel. He continues as Group General Counsel and Group Chief Compliance Officer until November 2030.
Religare Enterprises approved audited standalone and consolidated financial results for fiscal year 2026. The company reported consolidated net profit of ₹73.16 Crore.
Religare Enterprises appointed Mr. Srinivasan Karthik as CEO and Managing Director of its subsidiary Religare Finvest. The leadership change takes effect from May 05, 2026.
Religare's subsidiary, Care Health Insurance, received a rectification order reducing its tax liability to ₹45.16 Crore. The company continues to appeal the original assessment additions.
Religare Enterprises Limited has scheduled a Board meeting on May 12, 2026, to approve audited standalone and consolidated financial results for the year ended March 31, 2026. The company also confirmed its trading window remains closed until May 14, 2026.
Religare Enterprises Limited shareholders approved shifting the company's Registered Office from Delhi to Haryana. This involves an amendment to Clause II of the Memorandum of Association, subject to regulatory approvals. The move centralizes administrative operations in Haryana.
Religare Enterprises Limited announced the voting results of its EGM held on May 05, 2026. Shareholders approved shifting the registered office to Haryana and the appointment of Mr. Arjun Lamba as Whole Time Director with 98.48% and 95.53% majority respectively. The resolutions were passed as special resolutions via remote e-voting and poll.
Religare Enterprises Limited conducted an Extra Ordinary General Meeting on May 05, 2026, via video conferencing. Shareholders considered special resolutions regarding shifting the registered office from Delhi to Haryana and appointing Mr. Arjun Lamba as Whole Time Director. Voting results will be submitted separately after the scrutinizer's report.
Religare Enterprises' subsidiary, Care Health Insurance, received a rectification order reducing its tax liability for AY 2022-23 to ₹86.66 Crore from ₹173.32 Crore. The order corrects a technical error in the previous demand. An appeal against the original assessment remains pending with appropriate authorities.
Religare Enterprises Limited announced that Mr. Anuj Gulati's tenure as MD & CEO of its subsidiary, Care Health Insurance Limited, ended on April 25, 2026. The company acknowledged his leadership in building the entity into a leading health insurer. No replacement was named in this disclosure.
Religare Enterprises Limited announced the appointment of Mr. Manish Vishnu Dodeja as Whole-time Director of its material subsidiary, Care Health Insurance Limited. The appointment is for a five-year term effective April 26, 2026. IRDAI has already approved the appointment, which remains subject to shareholder approval.
Religare Enterprises Limited announced the appointment of Mr. Ajay Kumar Shah as MD & CEO of its subsidiary, Care Health Insurance Limited (CHIL). The five-year term is effective April 26, 2026, following IRDAI approval. Mr. Shah, currently CHIL's Chief Business Officer, brings over 30 years of experience to the role, subject to shareholder approval.
Non-promoter investor Ashish Dhawan acquired 7,00,000 equity shares (0.21% stake) of Religare Enterprises Limited through an open market purchase on April 17, 2026. This acquisition increases his total holding in the company from 4.25% to 4.46% (6.41% to 6.58% on a diluted basis).
Religare Enterprises Limited has convened an EGM on May 05, 2026. Key agenda items include shifting the registered office from Delhi to Haryana and the appointment of Mr. Arjun Lamba as Whole Time Director for a five-year tenure starting April 01, 2026.
Religare Enterprises Limited has convened an EGM on May 05, 2026, to approve shifting its registered office to Haryana and appointing Mr. Arjun Lamba as Whole Time Director for five years with an annual fixed salary of ₹9 Crore. The meeting will be conducted via video conferencing.
Religare Enterprises Limited has scheduled an Extra-Ordinary General Meeting (EGM) for May 05, 2026, at 11:00 A.M. The meeting will be conducted via video conferencing. The company will send the EGM notice electronically to registered members and make it available on its website and stock exchange platforms.